(Q50636042)

17 March 2018

title

Is acute rejection deleterious to long-term liver allograft function? (English)

1 reference

17 March 2018

author

Bertrand Dousset

1

1 reference

17 March 2018

author name string

F Conti

2

1 reference

17 March 2018

B Cherruau

3

1 reference

17 March 2018

A Louvel

4

1 reference

17 March 2018

O Soubrane

5

1 reference

17 March 2018

D Houssin

6

1 reference

17 March 2018

Y Calmus

7

1 reference

17 March 2018

publication date

1 October 1998

1 reference

17 March 2018

published in

Journal of Hepatology

1 reference

17 March 2018

volume

29

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

660-668

1 reference

17 March 2018

Patterns of graft rejection following liver transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Rejection in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Acute liver allograft rejection--is treatment always necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

One thousand liver transplants. The lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Stratifying the causes of death in liver transplant recipients. An approach to improving survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Surveillance for CMV infection in orthotopic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Histological findings in liver allograft rejection--new insights into the pathogenesis of hepatocellular damage in liver allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Indocyanine green clearance in acute rejection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Pharmacokinetics of the hepatic transport of organic anions: influence of extra- and intracellular binding on hepatic storage of dibromosulfophthalein and interactions with indocyanine green

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Hepatic clearance and liver blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Use of kinetic analysis and mathematical modeling in the study of metabolic pathways in vivo: applications to hepatic organic anion metabolism (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

MEGX test in hepatology: the long-sought ultimate quantitative liver function test?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Hepatitis C viral infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Liver regeneration in recipients and donors after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Cyclosporine augments hepatic regenerative response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

The beneficial effect of cyclosporine on liver ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Steroid withdrawal from long-term immunosuppression in liver allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Cancers complicating organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980163-3

7 January 2021

10.1016/S0168-8278(98)80163-3

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018